These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2530892
1. Effects of atenolol on left ventricular hypertrophy and early left ventricular function in essential hypertension. Allen JW, Kaiser PJ, Montenegro A. Am J Cardiol; 1989 Nov 15; 64(18):1157-61. PubMed ID: 2530892 [Abstract] [Full Text] [Related]
2. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA). Müller-Brunotte R, Kahan T, Malmqvist K, Ring M, Edner M. Am J Hypertens; 2006 Sep 15; 19(9):927-36. PubMed ID: 16942935 [Abstract] [Full Text] [Related]
3. Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment. Franz IW, Tönnesmann U, Behr U, Ketelhut R. Drugs; 1988 Sep 15; 35 Suppl 4():39-43. PubMed ID: 2967752 [Abstract] [Full Text] [Related]
4. Preserved ventricular pump function after a marked reduction of left ventricular mass. Ketelhut R, Franz IW, Behr U, Toennesmann U, Messerli FH. J Am Coll Cardiol; 1992 Oct 15; 20(4):864-8. PubMed ID: 1356116 [Abstract] [Full Text] [Related]
9. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Devereux RB, Dahlöf B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K. Circulation; 2004 Sep 14; 110(11):1456-62. PubMed ID: 15326072 [Abstract] [Full Text] [Related]
10. Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment. Corea L, Bentivoglio M, Verdecchia P. Hypertension; 1983 Sep 14; 5(6):837-43. PubMed ID: 6228528 [Abstract] [Full Text] [Related]
12. Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications. Zusman RM, Christensen DM, Higgins J, Boucher CA. J Cardiovasc Pharmacol; 1992 Aug 14; 20(2):216-22. PubMed ID: 1381012 [Abstract] [Full Text] [Related]
13. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Wachtell K, Dahlöf B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, Gerdts E, Boman K, Bella JN, Devereux RB. Am Heart J; 2002 Dec 14; 144(6):1057-64. PubMed ID: 12486431 [Abstract] [Full Text] [Related]
14. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil. Angermann CE, Spes CH, Willems S, Dominiak P, Kemkes BM, Theisen K. Circulation; 1991 Aug 14; 84(2):583-93. PubMed ID: 1830519 [Abstract] [Full Text] [Related]
20. Effect of atenolol on left ventricular function in hypertensive patients. Ibrahim MM, Madkour MA, Mossallam R. Clin Sci (Lond); 1980 Dec 14; 59 Suppl 6():473s-475s. PubMed ID: 7449301 [Abstract] [Full Text] [Related] Page: [Next] [New Search]